TCGA-BT-A20X-01A-11R-A16R-07
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
- overall_survival_months
- 8.245729304
- os_event
- true
- sex
- Male
GSVA pathway preview (50 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Top 10 elevated
- MYC_TARGETS_V2+0.470
- PROTEIN_SECRETION+0.450
- MYC_TARGETS_V1+0.440
- TNFA_SIGNALING_VIA_NFKB+0.370
- G2M_CHECKPOINT+0.360
- HYPOXIA+0.340
- IL6_JAK_STAT3_SIGNALING+0.310
- INFLAMMATORY_RESPONSE+0.310
- EPITHELIAL_MESENCHYMAL_TRANSITION+0.290
- INTERFERON_GAMMA_RESPONSE+0.290
Top 10 suppressed
- BILE_ACID_METABOLISM-0.380
- WNT_BETA_CATENIN_SIGNALING-0.260
- PEROXISOME-0.150
- XENOBIOTIC_METABOLISM-0.150
- ESTROGEN_RESPONSE_EARLY-0.110
- MYOGENESIS-0.090
- APICAL_SURFACE-0.070
- KRAS_SIGNALING_DN-0.050
- ESTROGEN_RESPONSE_LATE-0.030
- FATTY_ACID_METABOLISM-0.030
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
8 twins match this tumor's tissue · 2 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | fca4c327-dfab-4455-84a8-f890a7326132 | — | — | 0.879 |
| 2 | SRR29022839 | — | A | 0.863 |
| 3 | 2F14C141-CE43-4934-BEC9-769A181DB053 | — | — | 0.859 |
| 4 | TCGA-DK-A3WW-01A-22R-A23N-07 | — | — | 0.859 |
| 5 | TCGA-XF-A9SY-01A-21R-A42T-07 | — | — | 0.859 |
| 6 | BS_4QW2S1Q8 | high-grade glioma | — | 0.856 |
| 7 | c96595aa-4604-4ec6-8b54-c97b3543777e | — | — | 0.855 |
| 8 | SRR1516056 | — | — | 0.854 |
| 9 | SRR934869 | — | — | 0.849 |
| 10 | 266354 | EPN | EPN Tumor | 0.847 |